Science Abstracts
Novel therapeutics in metastatic bladder cancer
March 2010
March 2010
Authors : Alexandros Lekas1 , Thomas G Papathomas2 , Athanasios G Papatsoris3 , Charalambos Deliveliotis1 , Andreas C Lazaris2
Affliation :
1National and Kapodistrian University of Athens, Sismanoglio General Hospital, Medical School, 2nd Department of Urology, Athens, Greece
2Medical School, 1st Department of Pathology, Athens, Greece
3Barts and The London NHS Trust, Department of Urology, West Smithfield, EC1A 7BE, London, UK ;
DOI : 10.1517/13543780802514195
Published in : Expert Opin. Investig. Drugs
Subject:
Keywords: chemotherapy , metastatic urothelial carcinoma , novel biological agents
Abstract
Please Login to read the full article.
RELATED CONTENT
NEWS
- Avastin shows positive trend in large Phase II melanoma trial
- Genzyme's Clolar needs more study in acute myeloid leukaemia, US panel says
- Hopes high for Provenge to become first US-approved therapeutic cancer vaccine
- Mixed Phase III results for Erbitux in first-line colorectal cancer
COMMENT
Other Informa Comment
EVENTS
22 March 2010
London, UK
12 April 2010
Orlando, Florida
13 April 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
